
Alert: New Earnings Report (2/18/25)-Axsome Therapeutics Inc (NASDAQ: AXSM).
Axsome Therapeutics Inc (NASDAQ: AXSM) has reported E.P.S. of $-1.54 for its fourth fiscal quarter (ending December 31) versus $-2.08 for the same period a year ago — a decline of -26%. For the latest […]